Spyre Therapeutics, Inc. (SYRE)

44.00 -0.18 (-0.41%) USD  |  NASDAQ  |  Feb 24, 12:55
More

Spyre Therapeutics Foreign Sales (Quarterly)

Foreign Sales (Quarterly) Chart

View Foreign Sales (Quarterly) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Foreign Sales (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Foreign Sales (Quarterly) Range, Past 5 Years

View Foreign Sales (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Foreign Sales (Quarterly) Benchmarks

View Foreign Sales (Quarterly) Benchmarks
Start Trial
PTC Therapeutics, Inc. --
Tandem Diabetes Care, Inc. --
ACADIA Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. --
Savara, Inc. --